Awarded
2ª Prorroga (adelantada) Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- BIOGEN SPAIN S.L.
- Contract value
- €325,570
- Bids received
- 1
- Published
- 4 Aug 2025
- Awarded
- 30 Jul 2025
- Contract start
- 30 Jul 2025
- Contract end
- 31 Jul 2026estimated
- Region
- Madrid